Ionis Pharmaceuticals Statistics
Total Valuation
IONS has a market cap or net worth of $5.63 billion. The enterprise value is $5.13 billion.
Important Dates
The next estimated earnings date is Wednesday, February 19, 2025, before market open.
| Earnings Date | Feb 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IONS has 157.90 million shares outstanding. The number of shares has increased by 2.19% in one year.
| Current Share Class | 157.90M |
| Shares Outstanding | 157.90M |
| Shares Change (YoY) | +2.19% |
| Shares Change (QoQ) | +1.81% |
| Owned by Insiders (%) | 0.75% |
| Owned by Institutions (%) | 99.75% |
| Float | 156.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.47 |
| Forward PS | 9.25 |
| PB Ratio | 8.49 |
| P/TBV Ratio | 8.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.91, with a Debt / Equity ratio of 3.01.
| Current Ratio | 8.91 |
| Quick Ratio | 8.24 |
| Debt / Equity | 3.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.87 |
Financial Efficiency
Return on equity (ROE) is -73.38% and return on invested capital (ROIC) is -8.81%.
| Return on Equity (ROE) | -73.38% |
| Return on Assets (ROA) | -7.25% |
| Return on Capital (ROIC) | -8.81% |
| Revenue Per Employee | $866,307 |
| Profits Per Employee | -$387,067 |
| Employee Count | 927 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 33.95 |
Taxes
In the past 12 months, IONS has paid $3.02 million in taxes.
| Income Tax | 3.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.18% in the last 52 weeks. The beta is 0.36, so IONS's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -29.18% |
| 50-Day Moving Average | 37.43 |
| 200-Day Moving Average | 41.93 |
| Relative Strength Index (RSI) | 42.74 |
| Average Volume (20 Days) | 1,676,296 |
Short Selling Information
The latest short interest is 10.45 million, so 6.62% of the outstanding shares have been sold short.
| Short Interest | 10.45M |
| Short Previous Month | 11.05M |
| Short % of Shares Out | 6.62% |
| Short % of Float | 6.67% |
| Short Ratio (days to cover) | 7.74 |
Income Statement
In the last 12 months, IONS had revenue of $803.07 million and -$358.81 million in losses. Loss per share was -$2.46.
| Revenue | 803.07M |
| Gross Profit | -114.91M |
| Operating Income | -348.72M |
| Pretax Income | -352.50M |
| Net Income | -358.81M |
| EBITDA | -336.27M |
| EBIT | -348.72M |
| Loss Per Share | -$2.46 |
Full Income StatementBalance Sheet
The company has $2.49 billion in cash and $1.99 billion in debt, giving a net cash position of $496.19 million or $3.14 per share.
| Cash & Cash Equivalents | 2.49B |
| Total Debt | 1.99B |
| Net Cash | 496.19M |
| Net Cash Per Share | $3.14 |
| Equity (Book Value) | 662.47M |
| Book Value Per Share | 4.20 |
| Working Capital | 2.41B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$351.94 million and capital expenditures -$18.96 million, giving a free cash flow of -$370.91 million.
| Operating Cash Flow | -351.94M |
| Capital Expenditures | -18.96M |
| Free Cash Flow | -370.91M |
| FCF Per Share | -$2.35 |
Full Cash Flow StatementMargins
Gross margin is -14.31%, with operating and profit margins of -43.42% and -44.68%.
| Gross Margin | -14.31% |
| Operating Margin | -43.42% |
| Pretax Margin | -44.30% |
| Profit Margin | -44.68% |
| EBITDA Margin | -41.87% |
| EBIT Margin | -43.42% |
| FCF Margin | n/a |
Dividends & Yields
IONS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.19% |
| Shareholder Yield | -2.19% |
| Earnings Yield | -6.38% |
| FCF Yield | -6.59% |
Dividend DetailsAnalyst Forecast
The average price target for IONS is $62.00, which is 74.01% higher than the current price. The consensus rating is "Buy".
| Price Target | $62.00 |
| Price Target Difference | 74.01% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 20.71% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IONS has an Altman Z-Score of 1.5 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.5 |
| Piotroski F-Score | 4 |